Compare
ABCL · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
ABCL
AbCellera Biologics Inc
11.75
+0.13 (1.12%)
Valuation
| Market Cap | $3.84B |
|---|---|
| Enterprise Value | 3.18B |
| Income | -148.30M |
| Sales | 67.86M |
| Book / share | 3.26 |
| Cash / share | 2.42 |
| Dividend Gr. 3/5Y | - - |
| Employees | 562 |
| IPO | Dec 11, 2020 |
Ratios
| Price / sales | 56.55 |
|---|---|
| Price / book | 3.61 |
| Price / cash | 4.86 |
| Value / sales | 46.89 |
| Quick Ratio | 12.33 |
| Current Ratio | 12.43 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.12 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.48 |
|---|---|
| Earnings next year | -0.65 |
| Earnings next quarter | -0.16 |
| Earnings this year | -24.58% |
| Earnings growth, 5 years | -13.11% |
| Past earnings growth | - - |
| Past sales growth | -46.31% -20.27% |
| Earnings vs last year | 16.43% |
| Sales vs last year | 92.10% |
| Earnings vs last quarter | 32.97% |
| Sales vs last quarter | 18.81% |
| Earnings | Nov 09 AMC · 4 days ago |
| Surprise | 23.80% 26.41% |
Ownership
| Insiders own | 21.74% |
|---|---|
| Insider trades | 0.09% |
| Institutions own | 35.28% |
| Institution trades | -3.90% |
| Return on assets | -10.39% |
| Return on equity | -14.64% |
| Return on capital | -12.46% |
| Gross Margin | 49.93% |
| Operating margin | -297.97% |
| Profit Margin | -218.54% |
| 20-day average | -2.83% |
| 50-day average | -4.80% |
| 200-day average | 62.33% |
Technical
| Shares out | 326.33M |
|---|---|
| Shares floating | 255.61M |
| Short / float | 11.35% |
| Short ratio | 5.70 |
| Short interest | 29.02M |
| 52-week high | 15.02 -21.7% |
| 52-week low | 2.75 +328.1% |
| Volatility | 8.04% 8.05% |
| Average range | 0.91 |
| Strength index | 47.06 |
| Market sensitivity | 1.59 |
| Relative volume | 0.06 |
| Avg Volume | 5.09M |
| Volume | 15,526 |
Performance
| Perf Week | -1.09% |
|---|---|
| Perf Month | -7.33% |
| Perf Quarter | 4.91% |
| Perf Half Y | 187.29% |
| Perf YTD | 243.57% |
| Perf Year | 224.59% |
| Perf 3Y | 195.23% |
| Perf 5Y | -21.77% |
| Recommendation | 1.14 |
| Target Price | 18.00 |
| Prev Close | 11.62 |
| Price | 11.75 |
| Change % | 1.12% |
Compare
| ABCL | |
|---|---|
| Price | 11.75 |
| Change | +0.13 (1.12%) |
Compare · Valuation
| ABCL | |
|---|---|
| Market Cap | $3.84B |
| Enterprise Value | 3.18B |
| Income | -148.30M |
| Sales | 67.86M |
| Book / share | 3.26 |
| Cash / share | 2.42 |
| Dividend Gr. 3/5Y | - - |
| Employees | 562 |
| IPO | Dec 11, 2020 |
Compare · Ratios
| ABCL | |
|---|---|
| Price / sales | 56.55 |
| Price / book | 3.61 |
| Price / cash | 4.86 |
| Value / sales | 46.89 |
| Quick Ratio | 12.33 |
| Current Ratio | 12.43 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.12 |
| Options and short | Yes / Yes |
Compare · Earnings
| ABCL | |
|---|---|
| Earnings / share | -0.48 |
| Earnings next year | -0.65 |
| Earnings next quarter | -0.16 |
| Earnings this year | -24.58% |
| Earnings growth, 5 years | -13.11% |
| Past earnings growth | - - |
| Past sales growth | -46.31% -20.27% |
| Earnings vs last year | 16.43% |
| Sales vs last year | 92.10% |
| Earnings vs last quarter | 32.97% |
| Sales vs last quarter | 18.81% |
| Earnings | Nov 09 AMC · 4 days ago |
| Surprise | 23.80% 26.41% |
Compare · Ownership
| ABCL | |
|---|---|
| Insiders own | 21.74% |
| Insider trades | 0.09% |
| Institutions own | 35.28% |
| Institution trades | -3.90% |
| Return on assets | -10.39% |
| Return on equity | -14.64% |
| Return on capital | -12.46% |
| Gross Margin | 49.93% |
| Operating margin | -297.97% |
| Profit Margin | -218.54% |
| 20-day average | -2.83% |
| 50-day average | -4.80% |
| 200-day average | 62.33% |
Compare · Technical
| ABCL | |
|---|---|
| Shares out | 326.33M |
| Shares floating | 255.61M |
| Short / float | 11.35% |
| Short ratio | 5.70 |
| Short interest | 29.02M |
| 52-week high | 15.02 -21.7% |
| 52-week low | 2.75 +328.1% |
| Volatility | 8.04% 8.05% |
| Average range | 0.91 |
| Strength index | 47.06 |
| Market sensitivity | 1.59 |
| Relative volume | 0.06 |
| Avg Volume | 5.09M |
| Volume | 15,526 |
Compare · Performance
| ABCL | |
|---|---|
| Perf Week | -1.09% |
| Perf Month | -7.33% |
| Perf Quarter | 4.91% |
| Perf Half Y | 187.29% |
| Perf YTD | 243.57% |
| Perf Year | 224.59% |
| Perf 3Y | 195.23% |
| Perf 5Y | -21.77% |
| Recommendation | 1.14 |
| Target Price | 18.00 |
| Prev Close | 11.62 |
| Price | 11.75 |
| Change % | 1.12% |